Ashlin M Edick

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Signaling Pathway

Combination Therapy

Skeletal Muscle

Dna Damage Response

Top Venues

Nature communications

Molecular cancer therapeutics

American journal of physiology. Endocrinology and metabolism

McGill University (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

McGill University Aug 01 2018

Canada

MSC :: Animal Science

University of Guelph Sep 01 2014 - Jun 13 2018

Canada

BSC :: Animal Biosciences

Publications

Meiou Dai, Gang Yan, Ni Wang, Girija Daliah, Ashlin M Edick, Sophie Poulet, Julien Boudreault, Suhad Ali, Sergio A Burgos, Jean-Jacques Lebrun
In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy. Nature communications 12 (1) (2021)
Ashlin M Edick, Olivia Auclair, Sergio A Burgos
Role of Grb10 in mTORC1-dependent regulation of insulin signaling and action in human skeletal muscle cells. American journal of physiology. Endocrinology and metabolism 318 (2) (2019)
Hong Zhu, Congye Wu, Ting Wu, Wen Xia, Shusheng Ci, Lingfeng He, Yilan Zhang, Lulu Li, Shiying Zhou, Jing Zhang, Ashlin M Edick, Anna Zhang, Fei-Yan Pan, Zhigang Hu, Zhigang Guo
Inhibition of AKT Sensitizes Cancer Cells to Antineoplastic Drugs by Downregulating Flap Endonuclease 1. Molecular cancer therapeutics 18 (12) (2019)